Back
MGP Ingredients 10K Form
Sell
29
MGPI
MGP Ingredients
Last Price:
45.50
Seasonality Move:
8.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | MGPI/MGP Ingredients Quarterly |
2023-11-02 | 10Q | MGPI/MGP Ingredients Quarterly |
2023-08-03 | 10Q | MGPI/MGP Ingredients Quarterly |
2023-05-04 | 10Q | MGPI/MGP Ingredients Quarterly |
2022-11-03 | 10Q | MGPI/MGP Ingredients Quarterly |
2022-08-04 | 10Q | MGPI/MGP Ingredients Quarterly |
Receive MGPI News And Ratings
See the #1 stock for the next 7 days that we like better than MGPI
MGPI Financial Statistics
Sales & Book Value
Annual Sales: | $836.52M |
---|---|
Cash Flow: | $24.48M |
Price / Cash Flow: | 23.59 |
Annual Sales: | $41.66 |
Price / Book: | 1.09 |
Profitability
EPS (TTM): | 4.81000 |
---|---|
Net Income (TTM): | $107.69M |
Gross Margin: | $304.71M |
Return on Equity: | 12.41% |
Return on Assets: | 7.67% |
MGP Ingredients Earnings Forecast
Key MGP Ingredients Financial Ratios
- The Gross Profit Margin over the past 36 years for MGPI is 36.43%.
- The Selling, General & Administrative Expenses for MGPI have been equal to 15.49% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 6.18% of Operating Income.
- The Net Earning history of MGPI is 12.85% of Total Revenues.
- Per Share Earnings over the last 36 years have been positive in 21 years.
MGP Ingredients Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Beverages |
Sector: | Consumer Staples |
Current Symbol: | MGPI |
CUSIP: | 55303J |
Website: | mgpingredients.com |
Debt
Debt-to-Equity Ratio: | 0.32 |
---|---|
Current Ratio: | 6.46 |
Quick Ratio: | 1.88 |
Price-to-Earnings
Trailing P/E Ratio: | 9.48 |
---|---|
Forward P/E Ratio: | 12.24 |
MGPI Technical Analysis vs Fundamental Analysis
Sell
29
MGP Ingredients (MGPI)
is a Sell
Is MGP Ingredients a Buy or a Sell?
-
MGP Ingredients stock is rated a Sell
The current MGP Ingredients [MGPI] share price is $45.50. The Score for MGPI is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.